ACE Inhibitors (Milestones in Drug Therapy)

0 avg rating
( 0 ratings by Goodreads )
 
9783034875813: ACE Inhibitors (Milestones in Drug Therapy)

Angiotensin converting enzyme inhibitors (ACEI) represent the first class of antihypertensive agents that was designed and developed on the basis of a well-defined physiopathological axis of arterial hypertension, a vascular dis­ order that is now becoming one of the major causes of morbidity/mortality, not only in developed societies but also in the highly populated developing coun­ tries [1]. CAPTOPRIL, the prototype of the "PRIL" family, which now comprises more than 40 molecule-species, was quite hazardous and the clinical develop­ ment almost failed when serious side-effects were reported in an alarmist fash­ ion in reputable scientific journals, such as the New England Journal of Medicine and Lancet. Squibb & Sons came very close to withdrawing CAPTOPRIL from clinical investigation [2]. However, after re-examination of the data obtained from different categories of patients and appropriate dose-adjustments, the clinical use of CAPTOPRIL turned out to be revolutionary. The prototype, as well as other members of the "PRIL" family became the starting point for numerous basic and clinical research programs, focusing on the interactions of ACEI with the kinin, endothelin, and nitric oxide systems, and the contribution of the receptors for AT I, AT 2, bradykinin Bland B , ETA and ET B to the pharmacological actions 2 of the respective peptides. This research activity led to the development of new pharmacological agents, such as the angiotensin receptor antagonists and, more recently, the neutral endopeptidase inhibitors. In the near future, bradykinin receptor antagonists also will be available to modulate ACEI phar­ macological actions.

"synopsis" may belong to another edition of this title.

Buy New View Book
List Price: US$ 99.00
US$ 101.85

Convert Currency

Shipping: US$ 5.10
From United Kingdom to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

D'Orlà ans-Juste, Pedro
Published by Birkhäuser (2016)
ISBN 10: 3034875819 ISBN 13: 9783034875813
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Birkhäuser, 2016. Paperback. Book Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Bookseller Inventory # ria9783034875813_lsuk

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 101.85
Convert Currency

Add to Basket

Shipping: US$ 5.10
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

PEDRO D'ORLÉANS-JUSTE
Published by Birkhäuser (2012)
ISBN 10: 3034875819 ISBN 13: 9783034875813
New Paperback Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Birkhäuser, 2012. Paperback. Book Condition: NEW. 9783034875813 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE0416028

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 97.82
Convert Currency

Add to Basket

Shipping: US$ 10.55
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Pedro D'Orleans-Juste
Published by Springer Basel (2001)
ISBN 10: 3034875819 ISBN 13: 9783034875813
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Springer Basel, 2001. PAP. Book Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IQ-9783034875813

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 106.86
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

4.

Pedro D'Orleans-Juste
Published by Springer Basel (2001)
ISBN 10: 3034875819 ISBN 13: 9783034875813
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Springer Basel, 2001. PAP. Book Condition: New. New Book. Delivered from our UK warehouse in 3 to 5 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # LQ-9783034875813

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 99.06
Convert Currency

Add to Basket

Shipping: US$ 11.88
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Published by Birkhäuser (2001)
ISBN 10: 3034875819 ISBN 13: 9783034875813
New Softcover Quantity Available: 15
Print on Demand
Seller:
Rating
[?]

Book Description Birkhäuser, 2001. Book Condition: New. This item is printed on demand for shipment within 3 working days. Bookseller Inventory # LP9783034875813

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 132.22
Convert Currency

Add to Basket

Shipping: US$ 3.51
From Germany to U.S.A.
Destination, Rates & Speeds

6.

Published by Birkhäuser (2012)
ISBN 10: 3034875819 ISBN 13: 9783034875813
New Paperback Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Birkhäuser, 2012. Paperback. Book Condition: New. book. Bookseller Inventory # M3034875819

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 146.28
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

7.

Published by Springer Basel, Switzerland (2012)
ISBN 10: 3034875819 ISBN 13: 9783034875813
New Paperback Quantity Available: > 20
Print on Demand
Seller:
The Book Depository EURO
(London, United Kingdom)
Rating
[?]

Book Description Springer Basel, Switzerland, 2012. Paperback. Book Condition: New. Language: English . Brand New Book ***** Print on Demand *****.Angiotensin converting enzyme inhibitors (ACEI) represent the first class of antihypertensive agents that was designed and developed on the basis of a well-defined physiopathological axis of arterial hypertension, a vascular dis- order that is now becoming one of the major causes of morbidity/mortality, not only in developed societies but also in the highly populated developing coun- tries [1]. CAPTOPRIL, the prototype of the PRIL family, which now comprises more than 40 molecule-species, was quite hazardous and the clinical develop- ment almost failed when serious side-effects were reported in an alarmist fash- ion in reputable scientific journals, such as the New England Journal of Medicine and Lancet. Squibb Sons came very close to withdrawing CAPTOPRIL from clinical investigation [2]. However, after re-examination of the data obtained from different categories of patients and appropriate dose-adjustments, the clinical use of CAPTOPRIL turned out to be revolutionary. The prototype, as well as other members of the PRIL family became the starting point for numerous basic and clinical research programs, focusing on the interactions of ACEI with the kinin, endothelin, and nitric oxide systems, and the contribution of the receptors for AT I, AT 2, bradykinin Bland B , ETA and ET B to the pharmacological actions 2 of the respective peptides. This research activity led to the development of new pharmacological agents, such as the angiotensin receptor antagonists and, more recently, the neutral endopeptidase inhibitors. In the near future, bradykinin receptor antagonists also will be available to modulate ACEI phar- macological actions. Softcover reprint of the original 1st ed. 2001. Bookseller Inventory # AAV9783034875813

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 155.90
Convert Currency

Add to Basket

Shipping: US$ 3.96
From United Kingdom to U.S.A.
Destination, Rates & Speeds